Oesophageal Cancer Trial, Recruiting (NCT07264036)

Oesophageal Cancer Trial, Recruiting NCT07264036 Sponsor: Vanessa Torrecillas Condition: Oesophageal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07264036 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Oesophageal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older who speak English
People who have a history of head and neck cancer that was treated with surgery, radiation combined with chemotherapy, or both
People whose speech has been assessed by a clinician and found to have a quality called hypernasality, where too much air escapes through the nose during speech

Who may not be able to join:

People whose velopharyngeal dysfunction (a problem with the valve between the nose and throat during speech) is caused by something other than cancer, or is suspected to be
People for whom a procedure to add bulk to the back wall of the throat is considered medically unsuitable
People who need a more intensive level of monitoring for their cancer at this time
People who have surgery or other medical treatments to the throat area planned in the future that would interfere with taking part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vanessa Torrecillas, MD, University of Virginia

Phone: 434-924-2040

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07264036

Sponsor: Vanessa Torrecillas

Phase: Not Applicable

Status: Recruiting

Condition: Oesophageal Cancer

Trial contact: 434-924-2040

More information: https://clinicaltrials.gov/study/NCT07264036

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older who speak English
People who have a history of head and neck cancer that was treated with surgery, radiation combined with chemotherapy, or both
People whose speech has been assessed by a clinician and found to have a quality called hypernasality, where too much air escapes through the nose during speech

Who may not be able to join:

People whose velopharyngeal dysfunction (a problem with the valve between the nose and throat during speech) is caused by something other than cancer, or is suspected to be
People for whom a procedure to add bulk to the back wall of the throat is considered medically unsuitable
People who need a more intensive level of monitoring for their cancer at this time
People who have surgery or other medical treatments to the throat area planned in the future that would interfere with taking part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Vanessa Torrecillas

Registry

ClinicalTrials.gov

Start date

24 March 2026

Est. completion

1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Nasometry and FEES for Characterizing Velopharyngeal Dysfunction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov